Irlvixro WART REMOVER FOR COMMON PLANTAR WARTS

Manufacturer
Shenzhen Xituo Electronics Co., Ltd
Effective date
2025-12-26
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:28:41

Label at a glance#

ProductIrlvixro WART REMOVER FOR COMMON PLANTAR WARTS
Active ingredientSALICYLIC ACID
Label structure13 sections

Dosage and administration

wash affected area may soak wart in warm water for 5 minutes dry area thoroughly using the applicator, apply one drop at a time to sufficiently cover each wart let dry repeat this procedure once or twice daily as needed (until wart is removed) treatment may take up to 12 weeks

Storage and handling

store at 20–25°C (68–77°F) keep bottle tightly closed protect from freezing avoid excessive heat or flame

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

salicylic acid 15%

Purpose

OTC - PURPOSE SECTION

Wart remover

Use

INDICATIONS & USAGE SECTION

for the removal ofcommon and plantar warts

Warnings

WARNINGS SECTION

for external use only

Do not use

OTC - DO NOT USE SECTION

on moles, birthmarks, or warts with hair growing from them
on irritated skin or on any area that is infected or reddened
if you have diabetes or poor blood circulation

When Using

OTC - WHEN USING SECTION

avoid contact with eyes
if product gets into eyes, flush with water for 15 minutes

Stop Use

OTC - STOP USE SECTION

discomfort persists
excessive irritation occurs

Ask Doctor

OTC - ASK DOCTOR SECTION

discomfort persists
excessive irritation occurs

Keep Out Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

wash affected area
may soak wart in warm water for 5 minutes
dry area thoroughly
using the applicator, apply one drop at a time to sufficiently cover each wart
let dry
repeat this procedure once or twice daily as needed (until wart is removed)
treatment may take up to 12 weeks

Other information

STORAGE AND HANDLING SECTION

store at 20–25°C (68–77°F)
keep bottle tightly closed
protect from freezing
avoid excessive heat or flame

Inactive ingredients

INACTIVE INGREDIENT SECTION

ALCOHOL, PROPYLENE GLYCOL, WATER, PENTYLENE GLYCOL, OLETH-20, PEG-40 HYDROGENATED CASTOR OIL
CYMBOPOGON CITRATUS LEAF OIL, POLYETHYLENE GLYCOL 400

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
238466salicylic acid 15 % Topical SolutionPSN1
238466salicylic acid 150 MG/ML Topical SolutionSCD1
238466salicylic acid 15 % Topical SolutionSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87273-002-01Irlvixro WART REMOVER FOR COMMON PLANTAR WARTS30 mL in 1 BOTTLELIQUID301

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87273-00287273-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Irlvixro WART REMOVER FOR COMMON PLANTAR WARTSWART REMOVER FOR COMMON PLANTAR WARTSShenzhen Xituo Electronics Co., Ltd46d64dcc-d603-544a-e063-6394a90a176c2025-12-26WarningsExact identifier
ndc (package): 87273-002-01
ndc (product): 87273-002
ndc11 (package): 87273000201
spl id: 46d64dcc-d604-544a-e063-6394a90a176c
spl set id: 46d64dcc-d603-544a-e063-6394a90a176c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.